Active Ingredient
Bee venom
Bee Venom Pain-relief Bone Healing Cream
FDA Label NDC 84732-066
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Dongguan Haiyi Technology Co.,ltd. for the product Bee Venom Pain-relief Bone Healing Cream (NDC 84732-066). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, inactive ingredient, purpose section, warning, stop use, not use, out of children, how to use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Aqua, Glucosamine, calendula,Methylsulfonylmethane, Chondroitin, Vitamin K2.
Purpose Section
1.100% Quickly Eliminate joint pain;
2. Fully treat arthritis, osteoporosis, spinal disorders,gout and rheumatism;
3. Instantly pain-relief, non-recurrent, nonirritant;
4. Especially for older adults,
Warning
1).For external use only, avoid directcontact with eyes, lf you feel any
discomfort, stop using itand wash it with plenty of water. In severe cases,
pleaseseek medical attention in time.
2). Not allowed to be used ondamaged skin,
Stop Use
This product may cause allergic reactions in asmall number of people.
lf youexperience any discomfort,please stop using it immediately.
Not Use
Not suitable for use by children, pregnantor breast feeding people.
Out Of Children
KEEP THE PRODUCT OUT OF REACH OF CHILDREN to
How To Use
1.Clean and dry the skin.
2.Take an appropriate amount of soothing creamand applyit evenly on the painful joints or bones.
3.Gently massage with hands until absorbed.
4.Use 2-3 times a day to get better results.
Dosage
Use 2-3 times a day to get better results.
Package Label.Principal Display Panel
Label (2836f9934c824e5fafaa09473e1ccad4)
* Please review the disclaimer below.
